Guidelines for management of Bowen's disease

British Journal of Dermatology

Volumn 141, Issue 4, 1999, Pages 633-641

  Cox, N H ^a   Eedy, D J ^b   Morton, C A ^c  

^a CUMBERLAND INFIRMARY   (United Kingdom)

^b CRAIGAVON AREA HOSPITAL   (United Kingdom)

^c NONE

Author keywords

Bowen's disease; Guidelines; Treatment

Indexed keywords

ALPHA INTERFERON; FLUOROURACIL; ISOTRETINOIN;

BOWEN DISEASE; CANCER CHEMOTHERAPY; CANCER SURGERY; CAUTERIZATION; CLINICAL FEATURE; CRYOTHERAPY; EVIDENCE BASED MEDICINE; HISTOLOGY; HUMAN; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

ANTIMETABOLITES; BOWEN'S DISEASE; CARCINOMA, SQUAMOUS CELL; CAUTERY; CRYOTHERAPY; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; LASER SURGERY; LEG; MALE; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS;

EID: 0032718461     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.03100.x     Document Type: Review

References (93)

1. 1 Bowen JT. Precancerous dermatoses: a study of two cases of chronic atypical epithelial proliferation. J Cutan Dis 1912; 30: 241-55.
2. 2 Strayer DS, Santa Cruz DJ. Carcinoma in situ of the skin: a review of histopathology. J Cutan Pathol 1980; 7: 244-59.
3. 3 Bocking A, Chatelain R, Salterberg A, Hagedorn M, Gross G. Bowenoid papulosis. Classification as a low-grade in situ carcinoma of the epidermis on the basis of histomorphologic and DNA ploidy studies. Anal Quant Cytol Histol 1989; 11: 419-25.
4. 4 Sanchez Yus E, de Diego V, Urrutia S. Large cell acanthoma. A cytologic variant of Rowen's disease? Am J Dermatopath 1988; 10: 197-208.
5. 5 Lee M-M, Wick MM. Bowen's disease. CA Cancer J Clin 1990; 40; 237-42.
6. 6 Eedy DJ, Gavin AT. Thirteen-year retrospective study of Bowen's disease in Northern Ireland. Br J Dermatol 1987; 117: 715-20.
7. 7 Cox NH. Body site distribution of Bowen's disease. Br J Dermatol 1994; 130: 714-16.
8. 8 Thestrup-Pedersen K, Ravnborg L, Reymann F. Morbus Bowen. Acta Derm Venereol (Stockh) 1988; 68: 236-9.
9. 9 Reizner GT, Chuang TY, Elpern DJ, Stone JL, Farmer ER. Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population-based incidence report. J Am Acad Dermatol 1994; 31: 596-600.
10. 10 Kovacs A, Yonemoto K, Katsuoka K, Nishiyama S, Harhai I. Bowen's disease: statistical study of a 10 year period. J Dermatol 1996; 23: 267-74.
11. 11 Kossard S, Rosen R. Cutaneous Bowen's disease. An analysis of 1001 cases according to age, sex, and site. J Am Acad Dermatol 1992; 27: 406-10.
12. 12 Degos R, Civatte J, Letessier S. Maladie de Bowen cutance ou muqueuse. Ann Dermatol Syphiligr 1976; 103: 5-14.
13. 13 Binet O, Beltzer-Garelli E, Elbaz JS, Aron-Brunctiere R. Bowen's disease and squamous cell carcinoma of the palm. Dermatologica 1980; 161: 136-9.
14. 14 Gonzalez-Perez R, Gardeazabal I, Eizaguirre X, Diaz-Perez JL. Metastatic squamous cell carcinoma arising in Bowen's disease of the palm. J Am Acad Dermatol 1997; 36: 635-6.
15. 15 Beck DE, Pazio VW, Jagelman DG, Lavery IC, Perianal Bowen's disease. Dis Colon Rectum 1988; 31: 419-22.
16. 16 Sarmiento JM, Wolff BG, Burgart LJ, Frizelle FA, Ilstrup DM. Perianal Bowen's disease: associated tumors, human papillomavirus, surgery, and other controversies. Dis Colon Rectum 1997; 40: 912-18.
17. 17 Marchesa P, Fazio VW, Oliart S, Goldblum JR, Lavery IC. Perianal Bowen's disease: a clinicopathological study of 47 patients. Dis Colon Rectum 1997; 40: 1286-93.
18. 18 Baran R, Dupre A, Sayag J, Letessier S, Robins P, Bureau H. Bowen disease of the nail apparatus. Ann Dermatol Venereol 1979; 106; 227-33.
19. 19 Sau P, McMarlin SL, Sperling LC, Katz R. Bowen's disease of the nail bed and periungual area. A clinicopathologic analysis of seven cases. Arch Dermatol 1994; 130: 204-9.
20. 20 Goodman G, Mason G, O'Brien T. Polydactylous Rowen's disease of the nail bed. Austral J Dermatol 1995; 36: 164-5.
21. 21 Ragi G, Turner MS, Klein LE, Stoll HL. Pigmented Bowen's disease and review of 420 Bowen's disease lesions. J Dermatol Surg Oncol 1988; 14: 765-9.
22. 22 Mikhail GR. Cancers, precancers, and pseudocancers on the male genitalia. J Dermatol Surg Oncol 1980; 6: 1027-35.
23. 23 Patterson JW, Kao GF, Graham JH, Helwig EB. Bowenoid papulosis. A clinicopathologic study with ultrastructural observations. Cancer 1986; 57: 823-36.
24. 24 Gerber GS. Carcinoma in situ of the penis. J Urol 1994; 151: 829-33.
25. 25 Schwartz RA, Janniger CK. Bowenoid papulosis. J Am Acad Dermatol 1991; 24: 261-4.
26. 26 Goette K. Review of crythroplasia of Queyrat and its treatment, Urol 1976; 8: 311-15.
27. 27 Sanders N, Bedotto C. Recurrent carcinoma in situ of the conjunctiva and cornea (Bowen's disease). Am J Ophthalmol 1972; 74: 688-93.
28. 28 Mora RG, Perniciaro C, Lee B. Cancer of the skin in blacks. III. A review of nineteen black patients with Bowen's disease. J Am Acad Dermatol 1984; 11: 557-62.
29. 29 Hofmann C, Plewig G, Braun-Falco O. Bowenoid lesions, Bowen's disease and keratoacanthomas in long-term PUVA-treated patients. Br J Dermatol 1979; 101: 685-92.
30. 30 Reshad H, Challoner F, Pollock DJ, Baker H. Cutaneous carcinoma in psoriatic patients treated with PUVA. Br J Dermatol 1984; 110: 299-305.
31. 31 McKenna KE, Paterson CC, Handley J, McGinn S, Allen G. Cutaneous neoplasia following PUVA therapy for psoriasis. Br J Dermatol 1996; 134: 639-42.
32. 32 Yeh S ,How SW, Lin CS. Arsenical cancer of the skin. Histologic study with special reference to Bowen's disease. Cancer 1968; 21: 312-39.
33. 33 Yeh S. Skin cancer in chronic arsenicism. Hum Pathol 1967; 4: 469-85.
34. 34 Fiertz U. Catamnestic investigations of the side effects of therapy of skin diseases with inorganic arsenic. Dermatologica 1965; 131: 41-58.
35. 35 Shannon RL, Strayer DS. Arsenic-induced skin toxicity. Hum Toxicol 1989; 8: 99-104.
36. 36 Kettler AH, Rutledge M, Tschen JA, Buffone G. Detection of human papillomavirus in nongenital Bowen's disease by in situ DNA hybridization. Arch Dermatol 1990; 126: 777-81.
37. 37 Collina G, Rossi E, Betelli S et al. Detection of human papillomavirus in extragenital Bowen's disease using in situ hybridization and polymerase chain reaction. Am J Dermatopath 1995; 17: 236-41.
38. 38 Kawashima M, Favre M, Obalck S, Jablonska S, Orth G. Premalignant lesions and cancers of the skin in the general population: evaluation of the role of human papillomaviruses. J Invest Dermatol 1990; 95: 537-42.
39. 39 Lu S, Syrjanen K, Havu VK, Syrjanen S. Failure to demonstrate human papillomavirus (HPV) involvement in Bowen's disease of the skin. Arch Dermatol Res 1996; 289: 40-5.
40. 40 Inagi R, Kosuge H, Nishimoto S, Yoshikawa K, Yamantshi K. Kaposi's sarcoma-associated herpesvirus (KSHV) sequences in premalignant and malignant skin tumors. Arch Virol 1996; 141: 2217-23.
41. 41 Nishimoto S, Inagi R, Yamanishi K, Hosokawa K, Kakibuchi M, Yoshikawa K. Prevalence of human herpesvirus-8 in skin lestons. Br J Dermatol 1997; 137; 179-84.
42. 42 Mitsuishi T, Sata T, Matsukura T, Kawashima M. Human herpesvirus 8 DNA is rarely found in Bowen's disease of non-immunosuppressed patients. Br J Dermatol 1997; 136: 803-4.
43. 43 Cascajo CD, Reichel M, Sanchez JL. Malignant neoplasms associated with seborrheic keratoses. An analysis of 54 cases. Am J Dermatopathol 1996; 18: 278-82.
44. 44 Graham JH, Helwig EB. Bowen's disease and its relationship to systemic cancer. Arch Dermatol 1959; 80: 133-59.
45. 45 Graham JH, Helwig EB. Bowen's disease and its relationship to systemic cancer. Arch Dermatol 1961; 83: 76-96.
46. 46 Peterka ES, Lynch FW, Goltz RW. An association between Bowen's disease and cancer. Arch Dermatol 1961; 84: 623-9.
47. 47 Callen JP, Headington J. Bowen's and non-Bowen's squamous intraepithelial neoplasia of the skin. Relationship to internal malignancy. Arch Dermatol 1980; 116: 422-6.
48. 48 Chute CG, Chuang TY, Bergstralh EJ, Su WP. The subsequent risk of internal cancer with Bowen's disease. A population-based study. JAMA 1991; 266: 816-19.
49. 49 Reymann F, Ravnborg L, Schon G, Engholm G, Osterlind A, Thestrup-Pedersen K. Bowen's disease and internal malignant diseases: a study 581 patients. Arch Dermatol 1988; 124: 677-9.
50. 50 Marting TE, Abel ME, Gallagher DM. Perianal Bowen's disease and associated malignancies. Results of a survey. Dis Colon Rectum 1987; 30: 782-5.
51. 51 Arbesmann H, Ransohoff DF. Is Bowen's disease a predictor for the development of internal malignancy? A methodological critique of the literature. JAMA 1987; 257: 516-18.
52. 52 Lycka BAS. Bowen's disease and internal malignancy. A metaanalysis. Int J Dermatol 1989; 28: 531-3.
53. 53 Jaeger AB, Gramkow A, Hjalgrim H et al. Bowen disease and risk of subsequent malignant neoplasms. A population-based cohort study of 1147 patients Arch Dermatol 1999; 135: 790-793.
54. 54 Kao GF. Carcinoma arising in Bowen's disease. Arch Dermatol 1986; 122: 1124-6.
55. 55 Stout AP. Malignant manifestations of Bowen's disease. N Y J Med 1939; 39: 801-9.
56. 56 Jacobs DM, Sandles LG, Leboit PE. Sebaceous carcinoma arising from Bowen's disease of the vulva. Arch Dermatol 1986; 122; 1191-3.
57. 57 Saida T, Okabe Y, Uhara H. Bowen's disease with invasive carcinoma showing sweat gland differentiation. J Cutan Pathol 1989; 16: 222-6.
58. 58 Biesterfeld S, Pennings K, Grussendorf-Conen EI, Bocking A. Aneuploidy in actinic keratosis and Bowen's disease-increased risk for invasive squamous cell carcinoma? Br J Dermatol 1995; 133: 557-60.
59. 59 Newton JA, Camplejohn RS, McGibbon DH. Aneuploidy in Bowen's disease. Br J Dermatol 1986; 114: 691-4.
60. 60 Obalek S, Jablonska S, Beaudenon S, Walczak L, Orth G. Bowenoid papulosis of the male and female genitalia: risk of cervical neoplasia. J Am Acad Dermatol 1986; 14: 433-44.
61. 61 Tolia BM, Castro VL, Mouded IM, Newman HR. Bowen's disease of shaft of penis. Successful treatment with 5-fluorouracil. Urology 1976; 7: 617-19.
62. 62 Sturm HM. Bowen's disease and 5-fluorouracil. J Am Acad Dermatol 1979; 16: 513-22.
63. 63 Fulton JE Jr, Carter DM, Hurley HJ. Treatment of Bowen's disease with topical 5-fluorouracil under occlusion. Arch Dermatol 1968; 97: 178-80.
64. 64 Welch ML, Grabski WJ, McCollough ML et al. 5-fluorouracil iontophoretic therapy for Bowen's disease:. J Am Acad Dermatol 1997; 36: 956-8.
65. 65 Raaf JH, Krown SE, Pinsky CM et al. Treatment of Bowen's disease with topical dinitrochlorobenzene and 5-fluorouracil. Cancer 1967; 37: 1633-42.
66. 66 Stone N, Burge S. Bowen's disease of the leg treated with weekly pulses of 5% fluorouracil cream. Br J Dermatol 1999; 140; 987-8.
67. 67 Jansen GT, Dillaha CJ, Honeycutt WM. Bowenoid conditions of the skin: treatment with topical 5-fluorouracil. Southern Med J 1967; 60: 185-8.
68. 68 Plaza Lanza M, Ralphs I, Dawber RPR. Cryosurgery for Bowen's disease of the skin. Br J Dermatol 1980; 103 (Suppl. 18): 14.
69. 69 Graham GF, Clark LC. Statistical update in cryosurgery for cancers of the skin. In: Cryosurgery for Skin Cancers and Cutaneous Disorders (Zacarian S, ed.). St Louis: Mosby, 1985; 298-305.
70. 70 Holt PJ. Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery. Br J Dermatol 1988; 119: 231-40.
71. 71 Cox NH, Dyson P. Wound healing on the lower leg after radiotherapy or cryotherapy of Bowen's disease and other malignant skin lesions. Br J Dermatol 1995; 133: 60-5.
72. 72 Morton CA, Whitehurst C, Moseley H, MeColl JH, Moore JV, Mackie RM. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1995; 135: 766-71.
73. 73 Heising RA. Treatment of Bowen's disease of the ear by the combined use of cryosurgery and topical 5-fluorouracil. Cutis 1979; 24: 271-5.
74. 74 Ahmed I, Berth-Jones J, Charles-Holmes S, Ilchyshyn A. Comparison of cryotherapy versus curretaye in the treatment of Bowen's disease Br J. Dermatol 1999; 141 (Suppl. 55): 31.
75. 75 Veien SK, Veien NK, Hattel T, Laurberg G. Results of treatment of non-melanoma skin cancer in a dermatologic practice. A prospective study. Ugeskrift Laeger 1996; 158: 7213-5.
76. 76 Moritz DL, Lynch WS. Extensive Bowen's disease of the penile shaft treated with fresh tissue Mohs micrographic surgery in two separate operations. J Dermatol Surg Oncol 1991; 17: 374-8.
77. 77 Boynton KK, Bjorkman DJ. Argon laser therapy for perianal Bowen's disease: a case report. Lasers Surg Med 1991; 11: 385-7.
78. 78 Gordon KB, Garden JM, Robinson JK. Bowen's disease of the distal digit. Outcome of treatment with carbon dioxide laser vaporization. Dermatol Surg 1996; 22: 723-8.
79. 79 Landthaler M, Haina D, Brunner R et al. Laser therapy of Bowenoid papulosis and Bowen's disease. J Dermatol Surg Oncol 1986; 12: 1253-7.
80. 80 Robinson PJ, Carruth JA, Fairris GM. Photodynamic therapy: a better treatment for widespread Bowen's disease. Br J Dermatol 1988; 119; 59-61.
81. 81 Jones CM, Mang T, Cooper M, Wilson BD, Stoll HL Jr. Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol 1992; 27: 979-82.
82. 82 Svanberg K, Andersson T, Killander D et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br J Dermatol 1994; 130: 743-51.
83. 83 Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994; 69: 605-8.
84. 84 Stables GI, Stringer MR, Robinson DJ, Ash DV. The treatment of Bowen's disease by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1998; 139 (Suppl. 51): 74.
85. 85 Stables GI, Stringer MR, Robinson DJ, Ash DV. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 136: 957-60.
86. 86 Stables GI, Stringer MR, Robinson DV, Ash DV. Topical aminolaevulinic acid photodynamic therapy for the treatment of erythroplasia of Queyrat. Br J Dermatol 1999; 140: 514-517.
87. 87 Varma S, Anstey A, Wilson H et al. Photodynamic therapy for the treatment of Bowen's disease, solar keratoses, and superficial basal cell carcinomas: 12 months experience with a novel light source, Br J Dermatol 1998; 139 (Suppl. 51): 19.
88. 88 Blank AA. Schnyder UW. Soft-X-ray therapy in Bowen's disease and erythroplasia of Queyrat. Dermatologica 1985; 171: 89-94.
89. 89 Gordon KB, Roenick HH, Gendleman M. Treatment of multiple lesions of Bowen disease with isotretinoin and interferon alpha. Arch Dermatol 1997; 133: 691-3.
90. 90 Sonnex TS, Ralfs IG, de Plaza Lanza M, Dawber RP. Treatment of erythroplasia of Queyrat with liquid nitrogen cryosurgery. Br J Dermatol 1982; 106: 581-4.
91. 91 Papillon J. Chassard JL. Respective roles of radiotherapy and surgery in the management of epidermoid carcinoma of the anal margin. Dis Colon Rectum 1992; 35: 422-9.
92. 92 Baker EJ, Hobbs ER. Enhancement of the clinical margins of Bowen's disease by acetowhitening. J Dermatol Surg Oncol 1990; 16: 846-50.
93. 93 Schell BJ, Rosen T. Evaluation of acetowhitening in Bowen's disease. J Dermatol Surg Oncol 1990; 20: 740-2.